During the past decade, CHU de Nantes, Hopital Laennec conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 30 clinical trials were completed, i.e. on average, 32.6% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 17 clinical trials were completed. i.e. 37% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Nantes, Hopital Laennec" #1 sponsor was "Abbott Medical Devices" with 6 trials, followed by "Boehringer Ingelheim" with 6 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 5 trials sponsored and "Biogen" with 5 trials sponsored. Other sponsors include 107 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Nantes, Hopital Laennec" #1 collaborator was "Ministry of Health, France" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator and "Prothena Biosciences Limited" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Nantes, Hopital Laennec" are "Alzheimer's Disease" (10 trials), "Alzheimer Disease" (9 trials), "Parkinson's Disease" (7 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials) and "Cystic Fibrosis" (5 trials). Many other conditions were trialed in "CHU de Nantes, Hopital Laennec" in a lesser frequency.

Most popular intervention types in "CHU de Nantes, Hopital Laennec" are "Drug" (79 trials), "Device" (29 trials), "Other" (15 trials), "Procedure" (14 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Carboplatin" (5 trials), "placebo" (5 trials), "ELX/TEZ/IVA" (4 trials) and "IVA" (4 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Nantes, Hopital Laennec" are 138 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 51 active trials in "CHU de Nantes, Hopital Laennec". 3 are not yet recruiting, 28 are recruiting, 18 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 62 completed trials in CHU de Nantes, Hopital Laennec, 2 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Nantes, Hopital Laennec, 6 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 29 trials that are defined as “Not Applicable".